Global Biobanking Summit 2012

Biobanking remains a hot area of investment with a predicted growth of 30% by 2015.

1 3 October 2012

Currently in read only mode, sorry about that, please try again in a few hours.

5 speakers

  • Anne Bahr, Data Privacy Officer, Sanofi
  • Lesley Stubbins, Director of Human Biological Sample Management, GlaxoSmithKline
  • Eva Buren, Head of IT, Karolinska Institute Biobank
  • Kathi Shea Vice President BioServices Operations (President Elect ISBER)
  • Steve Kelly Sample and Data Management Capability Leader, AstraZeneca

1 known attendee

  • Veronica Araujo

Tell your friends!

Share this event with your friends on Twitter



See something wrong?

Report an issue with this event